30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

BONESUPPORT Announces Positive top-line data from the CERTiFy CERAMENT Study -

BONESUPPORT announced that the CERTiFy study (CERAMENT® Treatment of Tibia Plateau Fracture defects) comparing CERAMENT bone void filler met its primary endpoint of non-inferiority to autologous iliac bone graft. The prospective, multi-center, controlled trial enrolled 137 patients with fresh traumatic depression fractures of the proximal tibia at 20 centers in Germany. Patients were randomized to receive either CERAMENT BVF or autograft. (BONESUPPORT AB, 11/19/18)